• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部晚期直肠癌新辅助放化疗的最新进展

Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

作者信息

Kawai Kazushige, Ishihara Soichiro, Nozawa Hiroaki, Hata Keisuke, Kiyomatsu Tomomichi, Tanaka Toshiaki, Nishikawa Takeshi, Otani Kensuke, Yasuda Koji, Murono Koji, Sasaki Kazuhito, Watanabe Toshiaki

机构信息

Department of Surgical Oncology, The University of Tokyo.

出版信息

J Anus Rectum Colon. 2018 May 25;1(2):39-44. doi: 10.23922/jarc.2017-005. eCollection 2017.

DOI:10.23922/jarc.2017-005
PMID:31583299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6768670/
Abstract

Preoperative chemoradiotherapy (CRT) has been actively used in Europe and the United States to treat advanced low rectal cancer, and provides excellent local control. In Japan, however, the standard treatment is lateral lymph node dissection, and to date CRT has not been actively used. In recent years, an increasing number of Japanese institutions have been using preoperative CRT to treat locally advanced rectal cancer. In this review, we describe the latest trends in CRT under five headings: short-course or long-course radiation, efforts to improve combined chemotherapy, the addition of preoperative adjuvant chemotherapy, the watch and wait strategy, and the significance of lateral lymph node dissection in patients receiving CRT.

摘要

术前放化疗(CRT)已在欧美积极用于治疗晚期低位直肠癌,并能提供良好的局部控制。然而,在日本,标准治疗方法是侧方淋巴结清扫,迄今为止尚未积极应用CRT。近年来,越来越多的日本机构开始使用术前CRT治疗局部晚期直肠癌。在本综述中,我们将在以下五个标题下描述CRT的最新趋势:短程或长程放疗、改进联合化疗的努力、术前辅助化疗的添加、观察等待策略以及CRT患者侧方淋巴结清扫的意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1b/6768670/c3dac0014690/2432-3853-1-0039-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1b/6768670/3b621423646c/2432-3853-1-0039-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1b/6768670/c3dac0014690/2432-3853-1-0039-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1b/6768670/3b621423646c/2432-3853-1-0039-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1b/6768670/c3dac0014690/2432-3853-1-0039-g002.jpg

相似文献

1
Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer.局部晚期直肠癌新辅助放化疗的最新进展
J Anus Rectum Colon. 2018 May 25;1(2):39-44. doi: 10.23922/jarc.2017-005. eCollection 2017.
2
A review of preoperative chemoradiotherapy for lower rectal cancer.低位直肠癌术前放化疗综述
J Anus Rectum Colon. 2018 May 25;1(3):65-73. doi: 10.23922/jarc.2017-013. eCollection 2017.
3
Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer.术前放化疗后选择性侧方盆腔淋巴结清扫术治疗局部进展期直肠癌的疗效和预后因素。
Int J Colorectal Dis. 2018 Apr;33(4):367-374. doi: 10.1007/s00384-018-2974-1. Epub 2018 Feb 13.
4
[Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].巩固性新辅助治疗或全新辅助治疗后低位直肠癌的保直肠手术:初步报告
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):281-288. doi: 10.3760/cma.j.cn.441530-20200228-00096.
5
Preoperative Chemoradiotherapy Might Improve the Prognosis of Patients with Locally Advanced Low Rectal Cancer and Lateral Pelvic Lymph Node Metastases.术前放化疗可能改善局部晚期低位直肠癌合并侧方盆腔淋巴结转移患者的预后。
World J Surg. 2017 Mar;41(3):876-883. doi: 10.1007/s00268-016-3748-y.
6
Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).韩国结直肠外科学会(KSCP)新辅助同期放化疗后局部中低位进展期直肠癌巩固化疗的临床试验:一项多中心、随机对照试验(KONCLUDE)。
BMC Cancer. 2018 May 8;18(1):538. doi: 10.1186/s12885-018-4466-7.
7
[Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].[局部晚期高危直肠癌患者新辅助综合治疗的疗效与安全性分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Apr 25;22(4):349-356. doi: 10.3760/cma.j.issn.1671-0274.2019.04.007.
8
Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.基于治疗前影像学检查,对接受术前放化疗的晚期低位直肠癌患者行选择性侧方盆腔淋巴结清扫术。
Ann Surg Oncol. 2014 Jan;21(1):189-96. doi: 10.1245/s10434-013-3216-y. Epub 2013 Aug 21.
9
Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis.日本直肠癌患者术前使用替加氟-尿嘧啶间歇口服联合亚叶酸钙进行放化疗的疗效及短期结局:一项单中心经验回顾性分析
World J Surg Oncol. 2017 May 31;15(1):112. doi: 10.1186/s12957-017-1177-5.
10
Identification of Predictors of Recurrence in Patients with Lower Rectal Cancer Undergoing Neoadjuvant Chemotherapy: A Direct Comparison of Short-Course and Long-Course Chemoradiotherapy.识别接受新辅助化疗的低位直肠癌患者复发的预测因素:短程和长程放化疗的直接比较。
Oncology. 2019;96(2):70-78. doi: 10.1159/000492617. Epub 2018 Sep 18.

引用本文的文献

1
Enhancement of radiation therapy by indoleamine 2,3 dioxygenase 1 inhibition through multimodal mechanisms.通过多模态机制抑制吲哚胺 2,3 双加氧酶 1 增强放射治疗。
BMC Cancer. 2023 Jan 18;23(1):62. doi: 10.1186/s12885-023-10539-5.
2
Intervention Strategies to Reduce Surgical Site Infection Rates in Patients Undergoing Rectal Cancer Surgery.降低直肠癌手术患者手术部位感染率的干预策略。
In Vivo. 2022 Jan-Feb;36(1):439-445. doi: 10.21873/invivo.12722.
3
Prognoses in Pathologically Confirmed T1 Lower Rectal Cancer Patients with or without Preoperative Therapy: An Analysis Using the Surveillance, Epidemiology, and End Results Database.

本文引用的文献

1
Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial.改良 FOLFOX6 方案联合或不联合放疗对比氟尿嘧啶和亚叶酸钙联合放疗在局部进展期直肠癌新辅助治疗中的疗效:中国 FOWARC 多中心、开放标签、随机三臂 III 期临床试验的初步结果。
J Clin Oncol. 2016 Sep 20;34(27):3300-7. doi: 10.1200/JCO.2016.66.6198. Epub 2016 Aug 1.
2
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial.直肠癌患者新辅助5-氟尿嘧啶或卡培他滨联合放疗加或不加奥沙利铂:一项III期随机临床试验
J Natl Cancer Inst. 2015 Sep 14;107(11). doi: 10.1093/jnci/djv248. Print 2015 Nov.
3
术前治疗与否的经病理证实的 T1 低位直肠癌患者的预后:基于监测、流行病学和最终结果数据库的分析。
Oncology. 2022;100(2):82-88. doi: 10.1159/000521033. Epub 2021 Nov 24.
4
Evaluation and Predictive Factors of Complete Response in Rectal Cancer after Neoadjuvant Chemoradiation Therapy.直肠癌新辅助放化疗后完全缓解的评估及预测因素。
Medicina (Kaunas). 2021 Sep 30;57(10):1044. doi: 10.3390/medicina57101044.
5
Therapeutic significance of D3 dissection for low rectal cancer: a comparison of dissections between the lateral pelvic lymph nodes and the lymph nodes along the root of the inferior mesenteric artery in a multicenter retrospective cohort study.D3 清扫术治疗低位直肠癌的意义:多中心回顾性队列研究中侧方盆淋巴结清扫与肠系膜下动脉根部淋巴结清扫的比较。
Int J Colorectal Dis. 2021 Jun;36(6):1263-1270. doi: 10.1007/s00384-021-03858-1. Epub 2021 Feb 3.
6
Oncological Outcomes of Pathological T1 Lower Rectal Cancer Patients With or Without Preoperative Chemoradiotherapy.术前放化疗对 T1 期低位直肠癌患者的肿瘤学结局的影响。
In Vivo. 2020 Nov-Dec;34(6):3559-3564. doi: 10.21873/invivo.12199.
A multicenter phase II study of preoperative chemoradiotherapy with S-1 plus oxaliplatin for locally advanced rectal cancer (SHOGUN trial).一项关于S-1联合奥沙利铂术前放化疗用于局部晚期直肠癌的多中心II期研究(SHOGUN试验)。
Radiother Oncol. 2015 Aug;116(2):209-13. doi: 10.1016/j.radonc.2015.08.002. Epub 2015 Aug 31.
4
Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial†.同期放化疗、手术与诱导化疗后同期放化疗、手术的比较:西班牙 GCR-3 期随机临床试验的长期结果†。
Ann Oncol. 2015 Aug;26(8):1722-8. doi: 10.1093/annonc/mdv223. Epub 2015 May 8.
5
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer.日本结直肠癌学会(JSCCR)2014年结直肠癌治疗指南。
Int J Clin Oncol. 2015 Apr;20(2):207-39. doi: 10.1007/s10147-015-0801-z. Epub 2015 Mar 18.
6
A phase I dose escalation study of oxaliplatin plus oral S-1 and pelvic radiation in patients with locally advanced rectal cancer (SHOGUN trial).一项关于奥沙利铂联合口服S-1及盆腔放疗用于局部晚期直肠癌患者的I期剂量递增研究(SHOGUN试验)。
Radiat Oncol. 2015 Jan 23;10:24. doi: 10.1186/s13014-015-0333-8.
7
Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study.MRI 定义的局部进展期可切除 T3 直肠癌新辅助治疗中贝伐珠单抗两种方案的病理反应和安全性:一项随机、非对照 II 期研究。
Ann Oncol. 2014 Nov;25(11):2205-2210. doi: 10.1093/annonc/mdu377. Epub 2014 Aug 13.
8
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04.卡培他滨与奥沙利铂用于直肠癌术前多模式治疗:来自国家外科辅助乳腺和肠道项目R-04试验的手术终点
J Clin Oncol. 2014 Jun 20;32(18):1927-34. doi: 10.1200/JCO.2013.53.7753. Epub 2014 May 5.
9
Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control.新辅助放化疗后完全临床缓解和观察等待的直肠癌局部复发:挽救治疗对局部疾病控制的影响。
Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):822-8. doi: 10.1016/j.ijrobp.2013.12.012. Epub 2014 Feb 1.
10
Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer.ACCORD 12/0405 PRODIGE 2 随机临床试验在直肠癌中的临床结果。
J Clin Oncol. 2012 Dec 20;30(36):4558-65. doi: 10.1200/JCO.2012.42.8771. Epub 2012 Oct 29.